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Areas for research 
Is there a common cause for neuropsychiatric consequences of stroke, which might explain 
the overlapping symptoms? 
What factors are associated with anxiety, emotional lability and post stroke fatigue without 
mood disorder? 
What is the natural course of post stroke anxiety and emotional lability? 
How should post stroke depression, emotional lability, fatigue and apathy be treated 
(including dose and duration of treatment)? 
Can these neuropsychiatric consequences of stroke be prevented by early intervention after 
stroke? 
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Abstract  
The most common neuropsychiatric consequences of stroke include depression, anxiety, 
fatigue and apathy, each occurring in at least 30% of patients, with considerable overlap of 
prevalence and symptoms. Emotional lability, personality change, psychosis and mania are less 
common but are equally distressing symptoms which are also challenging to manage. The 
cause of these syndromes is uncertain, and there is no clear relationship with brain lesion 
location. There are important gaps in our knowledge about how to manage them; even for 
depression which is the most well-studied syndrome.  Further research is needed to identify 
causes, and interventions to prevent and treat these syndromes. 
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Introduction  
Each year, about 16 million people in the world experience a first-ever stroke. Of these about 
5.7 million die and another 5 million remain disabled.1 Neuropsychiatric consequences of 
stroke are common, can be distressing to patients and their families and often represent an 
unmet need for treatment.2 
This review focuses on the most common non-cognitive neuropsychiatric consequences of 
stroke namely depression, anxiety, emotional lability and apathy; we also include fatigue 
(which is generally categorised as ‘neuropsychiatric’) and discuss personality change, 
psychosis and mania. For each consequence, we discuss definition and identification, 
prevalence, associations, natural history/outcome, prevention and treatment, based on our 
literature searches, then make recommendations for future research.  Researchers have tended 
to consider each neuropsychiatric consequence separately, so we follow this same approach, 
acknowledging though that there is considerable overlap between the syndromes. We include 
intracerebral haemorrhage and ischaemic stroke. We did not specifically search for, or include 
papers focusing on transient ischaemic attacks or subarachnoid haemorrhage. We do not 
include dementia.  
 
Our approach to the literature 
We searched Medline using the terms ‘stroke’, and each neuropsychiatric problem in turn, to 
identify systematic reviews and primary research (box).  These searches complemented 
previous searches we had performed, and so Medline was not necessarily searched from its 
inception. We scrutinised the Cochrane Stroke Group list of reviews and the Royal College of 
Physicians (RCP) Guidelines for stroke (2012)3 for which extensive literature searches had 
been performed. We screened reference lists of reviews. Our management recommendations 
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are based on data from randomised controlled trials (RCTs) or meta-analyses of RCTs but not 
from uncontrolled case series.  In the absence of such data, we provide consensus 
recommendations.   
 
Depression 
The US Diagnostic and Statistical Manual of Mental Disorders, DSM-54 requires ‘depressed 
mood’ or ‘anhedonia/loss of interest or pleasure’ for at least two weeks, plus at least four other 
symptoms which are persistent and interfere with daily life (‘significant weight loss/gain; 
insomnia or hypersomnia; psychomotor agitation or retardation; fatigue or loss of energy; 
worthlessness or inappropriate guilt; diminished concentration or indecisiveness’).  
In busy and resource-poor clinical settings, it is often appropriate to first use an interviewer-
administered or self-completed depression case-finding or screening tool, validated for use in 
stroke5 (e.g. the 9-item Patient Health Questionnaire6, The Center of Epidemiological Studies-
Depression Scale 7, Hospital Anxiety and Depression Scale (HADS), the Hamilton Depression 
Rating Scale and the Beck Depression Inventory8. 
When diagnosing depression,  consideration may be given to ensure somatic symptoms such 
as psychomotor retardation, fatigue, sleep and appetite disturbances are related to mood, and 
not to the physical symptoms of stroke. However, this is difficult to implement in practice and 
there is evidence that psychomotor retardation and fatigue are highly sensitive for depression 
after stroke.9  These symptoms are unpleasant and the clinical goal should be to reduce all 
unpleasant symptoms where possible. Equally important is the need to ensure that disturbances 
in behaviour, facial expression and verbal communication resulting from the stroke event do 
not mask symptoms of depression. 
RCP guidelines3 recommend that all stroke patients are screened for mood disorders within 6 
weeks. However, such screening is only worthwhile if followed by a fuller clinical diagnostic 
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assessment and an agreed management plan.10 Observer rated screening tools (e.g. Stroke 
Aphasic Depression Questionnaire11 or The Depression Intensity Scale Circles12) can be used 
to identify mood disturbance in people with aphasia or other communication problems; 
however, as for other screening, clinical judgement is then needed to decide if the patient has 
depression and whether treatment is needed. 
Depression occurs more frequently after stroke than in the general population. Data in two 
independent systematic reviews (43 cohorts, 20,293 people13 and 51 cohorts including 25,207 
people14; 21 cohorts included in both reviews) indicate that between 29%13 and 33%14 of stroke 
patients experience depression up to one year after stroke. Estimates from individual studies 
assessing major depression meeting DSM criteria varied across studies from 2% during 
admission15 in one cohort to 31% at three months in a different cohort.16 In the latter cohort, 
major depression meeting DSM criteria was assessed over three years. Estimates were 31% at 
three months, 16% at 1 year, 19% at 2 and 29% at three years after stroke (only 50 participants 
remained in the final cohort). 16  
Population based stroke registers with long-term follow-up17-19 demonstrate that depression 
after stroke is a chronic relapsing disorder. Of people with depression at the first assessment, 
between 13%18 and 52%19 still had depression at a year. Approximately 15% of those without 
depression at initial assessment developed depression during the first year.17, 19 
One systematic review of observational studies of depression after stroke (20 cohorts, 
n=17,934) indicates that only physical disability, stroke severity and cognitive impairment 
consistently show a positive association with depression (note that most included studies 
excluded people with pre-stroke depression).20 A second independent review using different 
methods included 10 cohorts (n=16,045)13 and identified pre-stroke depression as being 
associated with subsequent depression after stroke, in addition to disability, stroke severity, 
cognitive impairment. Variables not associated with depression include older age, being 
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female, having diabetes, stroke subtype, level of education, living alone or previous stroke.20 
Only one cohort was included in both reviews. Only a small proportion of the variation in 
depression was accounted for, though the included studies generally had sample sizes which 
were too small for multivariate analyses.  
A Cochrane review of pharmacological or psychological interventions to prevent post-stroke 
depression identified 14 trials involving 1515 people21, and reported a small but significant 
effect for psychological interventions (of various types) (4 trials) but no evidence of effect of 
antidepressants (10 trials) (figure 1). Four small antidepressant trials22-25 (384 people) 
potentially meeting Cochrane criteria have been published since the 2008 update, three22, 24, 25 
showed some evidence of benefit of antidepressants, though their inclusion in the Cochrane 
review is unlikely to significantly change overall estimates of effect. 
A Cochrane review of pharmacological or psychological interventions to treat depression after 
stroke identified 16 trials recruiting 1655 people26 (figure 1) and showed that antidepressants 
(13 trials) are minimally effective (no evidence of differences in efficacy between  
antidepressants) with an increase in gastrointestinal and central nervous system (e.g. confusion, 
sedation, tremor) side effects.  This is in line with a systematic review of trials in the general 
population showing antidepressants are minimally effective for mild to moderate depression,27 
but of substantial benefit for severe depression. The Cochrane review found no evidence of 
effectiveness for psychological therapies alone (4 trials) in treating depression after stroke.26 
One small antidepressant treatment trial (150 people) possibly meeting review criteria was 
identified since this review and showed a small benefit of treatment.28 
The United Kingdom Royal College of Physicians guidance is that support and advice is the 
first-line management for patients with mild or moderate symptoms of depression, and 
psychosocial interventions should be considered3. These guidelines also recommend increased 
social interaction, exercise and goal setting (though  our searches found insufficient evidence 
Printed 27 Sep 2013 
to support or refute their effectiveness).3 The American 29and European 30guidelines 
recommend pharmaceutical treatment (Selective Serotonin Reuptake Inhibitors or 
heterocyclics) for patients with depression 29, 30  The guidelines recommend that treatment 
should be monitored for effectiveness, and antidepressants (if used) continued for at least 6 
months after initial recovery. The choice of antidepressants for individual antidepressants can 
be guided by side effect profile e.g. antidepressants with sedative properties may be appropriate 
in patients with disturbed sleep.     
 
Anxiety 
The DSM-54 describes several anxiety disorders. Anxiety symptoms that are ‘out of proportion 
to the actual threat or danger the situation poses’, must be present for six months to meet 
diagnostic criteria for a Generalised Anxiety Disorder, plus at least three of the following 
symptoms: feeling wound-up, tense or restless; fatigued; difficulty concentrating; irritability; 
significant muscle tension; difficulty sleeping. To our knowledge, the HADS 8 is the only 
anxiety-specific case-finding tool validated for use in stroke research and clinical settings with 
published sensitivity and specificity data.31, 32 If the HADS is used to screen for anxiety, then 
as with other screening tools clinical judgement is then needed to decide if the patient has 
clinically significant anxiety and whether treatment is needed. 
A systematic review (39 cohorts including 4,706 people) indicated that 24% of stroke patients 
had anxiety symptoms as assessed by a rating scale, and 18% experienced an anxiety disorder, 
over the first five years after stroke.33 In this review, three cohort studies (856 people) reported 
anxiety in individual participants over time; the proportion with persistent anxiety ranged from 
38% to 76%. 
Studies evaluating factors correlated with anxiety in more than five cohorts have been 
narratively (but not systematically) reviewed.33 Depression was positively correlated with 
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anxiety in six of six cohorts and quality of life was negatively correlated with anxiety in four 
of five cohorts. No association was found with age, sex or brain lesion location. The factors 
associated with anxiety in people without depression after stroke are unknown.  
There are no studies on anxiety  prevention  after stroke. A Cochrane review of interventions 
to treat anxiety after stroke identified two trials involving 175 people.34 Both trials included 
people with co-morbid anxiety and depression and neither was placebo-controlled. 
Antidepressants alone or with psychotherapy may reduce anxiety symptoms but there is 
insufficient evidence from the Cochrane review to inform clinical practice. 
Emotional lability 
Emotional lability is described as ‘unstable emotional experiences and frequent mood changes; 
emotions that are easily aroused, intense and/or out of proportion to events and circumstances’.4 
It is also referred to as emotionalism, pathological laughing/crying, emotional incontinence, 
involuntary emotional expression disorder and pseudobulbar affect. There is no standard 
method of assessment. It usually presents as an increase in crying or, less commonly, laughing, 
and may co-exist with depression or depressive symptoms but can occur without depression.  
Symptoms are generally mild and transient, but when severe can cause great distress, 
embarrassment and avoidance of social contact.  
A few high quality studies reported that the frequency of emotional lability35-41 varies across 
individual studies from 8%35 at four months in one cohort to 32%37 three to 12 months after 
stroke in another. Symptoms are thought to reduce over the six months following stroke.36. The 
factors associated with reduction of symptoms are unknown. 
There are no published systematic reviews of the associations of emotional lability after stroke. 
Most research has focused on biological explanations with an association between emotional 
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lability and frontal lesions found in four cohorts36, 41-43 and an association with dorsal lesions 
in the other.44 
A Cochrane review of pharmacological interventions to treat emotional lability after stroke 
(seven trials, 739 people, recruited at 6 days to 13 years after stroke) reported that 
antidepressants reduced its frequency and severity but confidence intervals were wide (figure 
2).45 It is reasonable to use antidepressants for persistent emotional lability that is frequent and 
severe enough to warrant the known risks of antidepressants3; but the optimum type, duration 
or dose is unknown. 
 
Post-stroke Fatigue 
There is no standardised definition for post-stroke fatigue.46 Physiological (or normal) fatigue 
(a state of general tiredness which develops acutely after overexertion and improves after rest) 
and pathological fatigue (‘constant weariness unrelated to previous exertion levels and not 
usually ameliorated by rest’).47 tend to be distinguished in the literature, and in neurological 
diseases, ‘pathological fatigue’ is more prominent than ‘physiological’ fatigue.48 Post-stroke 
fatigue can be identified using a self-report fatigue scale, 46 or by structured interview to 
establish fulfilment of a case definition (analogous to a structured interview to identify 
depression). 47 There is little empirical evidence to support the concepts of ‘Primary’, 
‘secondary’, ‘central’ and ‘peripheral’ fatigue in stroke . The proportion of people with post-
stroke fatigue ranges from 23% to 75%, according to case mix, and how fatigue is identified. 
46
 Using a case definition, about 40% of stroke patients have fatigue. 49 
A systematic review of 9 longitudinal cohort studies (n=959) reported that the frequency of 
fatigue declined over time in seven studies (n=764) and increased in two studies (n=195). 50 
Two subsequent studies reported that fatigue frequency was stable  over time.51 52(table) 
Fatigue tends to persist in individual patients if present early after stroke. 50 
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The nature of post-stroke fatigue is different from fatigue experienced before stroke 53 and it 
seems to start around the time of the stroke.54  There is no clear association with brain lesion 
location55,  little evidence about biological correlates.55 and one study demonstrating 
associations with attentional deficits.51  A literature review in 2011 reported associations with 
depression, pain and poor sleep.46 Fatigue in conditions other than stroke is associated with 
reduced physical activity; whether this applies in stroke is uncertain.56  
A Cochrane review of 3 small randomised trials (142 people) which included fatigue as an 
outcome measure found no effective preventative or treatment strategies .57 One subsequent 
trial (n=83) without a control arm showed that treadmill aerobic training and cognitive 
behavioural therapy (CBT) together was better than CBT alone to treat post-stroke fatigue, 58A 
small trial (n=19) demonstrated that group education was a feasible treatment.59 Screening for 
fatigue is not currently recommended in guidelines. In patients with post-stroke fatigue, we 
suggest seeking potentially reversible causes e.g. anaemia, treating depression (if present), and 
in patients without patients without a clinical mood disorder or reversible medical problem, 
considering graduated exercise and cognitive behavioural approaches e.g.  activity scheduling 
3
.  
 
Apathy  
Apathy is a disorder of motivation with diminished goal-directed behaviour and cognition60 
which has its own distinct biological correlates, clinical course and treatment. Nevertheless 
phenomenological overlap (e.g. affective blunting, loss of interest, psychomotor retardation) 
with depression can make differential diagnosis difficult.60 Apathy can be identified by 
informant-rated scales e.g. Apathy Scale61 or Apathy Evaluation Scale62 ( designed and tested 
for use in brain-injured populations) or the generic Neuropsychiatric Inventory (NPI), also 
requiring an informant, which rates frequency and severity of several neuropsychiatric 
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symptoms (delusions, hallucinations, agitation, depression, anxiety, mood elation, apathy, 
disinhibition, irritability, aberrant motor behaviour, sleep, appetite).63 Diagnostic criteria for 
apathy have recently been proposed,64 requiring diminished motivation (core feature) for four 
weeks or more, two other symptoms (reduced goal-directed behavior, goal-directed cognitive 
activity, or emotions), and functional impairments. Symptoms and states that mimic apathy 
should be excluded. These criteria largely build on studies in apathy in dementia; whether they 
are appropriate for stroke is uncertain. 
In a meta-analysis of 2,706 patients from 24 studies, the mean prevalence of apathy was 34.6% 
at a median of 120 days post stroke.65 Another meta-analysis found similar figures.66 Apathy 
is more common in women,65 in studies using clinician-ratings compared to self-ratings or 
informant-ratings,65 and in recurrent strokes.66 
We identified three prospective studies (recruiting 408, 106 and 145 stroke patients), but 
methodological differences make direct comparisons difficult. The proportion whose apathy 
had remitted at follow-up ranged from 44% 67 to 67% 68. The development of new apathy 
during follow-up occurred in only 7% of patients 69.   
In cross-sectional studies, apathy is associated with less education, cognitive impairment 
(particularly attention, concentration, working memory and reasoning)70 and increasing 
disability.65, 66 Depression co-occurs in about 40% of apathetic patients.65 No convincing 
evidence links brain lesion location or stroke type to post-stroke apathy.65 We identified one 
publication that studied risk factors for apathy prospectively;, new incident apathy 15 months 
after stroke was predicted by a diagnosis of dementia three to six months after stroke, but not 
by age, gender, stroke severity, previous psychiatric history, current depressive symptoms, or 
living with a family member.67 Apathy is associated with worse functional outcome,71-73 and a 
higher risk of subsequent depression.67 
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There is insufficient evidence for treatment recommendations for post-stroke apathy. One RCT 
in 137 stroke patients with depression showed that 900mg/day nefiracetam for ≥4 weeks 
resulted in a greater change in scores of the Apathy Scale (secondary outcome) compared to 
600mg and placebo.74 
 
Mania 
Mania is defined as a prominent and persistently elevated, expansive or irritable mood, 
accompanied by changes in energy or activity, not accounted for by another mental disorders 
and not exclusively present in the course of delirium.4 Accompanying symptoms include 
hyperactivity, pressured speed, flight of ideas, grandiosity, decreased sleep, distractibility, or 
lack of judgement. Symptoms have to cause significant distress or impairment in social, 
occupation or other important functions. The clinical profile in post-stroke mania is similar to 
that of primary mania.75, 76  We identified three scales for rating the severity of manic symptoms 
35-37
 but no studies that have actually used these scales with stroke patients. 
The literature on mania after stroke is meagre. Its prevalence is considered to be low (≤ 2%), 
yet good epidemiological data are lacking.70 A systematic review of all studies published in the 
past 50 years identified 32 reports including only 49 patients, mostly gathered from single case 
or small case series reports.76 Delirium as a potential cause was specified in only about half of 
patients and a medical doctor or psychologist had conducted the interview in a minority (22%). 
Onset in these 49 patients was generally reported to be insidious; about half develop manic 
symptoms within the first days after stroke and the rest 1 to 24 months after stroke.76 The 
prevalence of single manic symptoms has been reported for euphoria/elated mood using the 
NPI; prevalence estimates range from 1% to 14%.68, 77-79    
Our literature search identified no prospective studies on the course of mania after stroke, no 
studies reporting associations (other than the review of 49 individual cases which described the 
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typical patient as being male, having vascular risk factors and a lesion in the right hemisphere) 
and no trials of interventions for prevention or treatment. No conclusive associations have been 
found with single symptoms of euphoria/elated mood.    
 
Personality disorders after stroke 
The DSM-V differentiates three clusters of Personality disorders .4 In order to classify as 
personality disorder, the changes have to be long-standing and hence require long follow-up of 
individual patients. We are not aware of any such study in stroke. A cross-sectional survey in 
the UK reported personality disorders in 0.8% of individuals with stroke compared to 0.4% 
without stroke; it is unclear whether personality disorder might have preceded the stroke.80 
  
Personality changes, including disinhibition and irritability 
Personality changes after stroke are not well defined and at times are used as an umbrella term 
for any neuropsychiatric syndrome, especially apathy.70 Assessing change in personality can 
be challenging, because information on pre-stroke personality might not be available. The NPI 
asks informants to consider only changes in a patient’s behaviour since illness onset. It includes 
questions on disinhibition and irritability, which are often classified as personality changes,81 
and are among the most distressing symptoms for carers and family members.82, 83 Irritability 
is characterized by impatience, flashes of anger, rapid mood changes, or quarreling,79 and 
disinhibition by impulsivity, tactlessness or – albeit less often – by vulgarity.79 
Prevalence estimates for irritability vary from 12-53%.68, 77 In a study of 274 institutionalized 
stroke patients, it was the more common  (prevalence 52.9%)  than depressive symptoms 
(52.6%) or apathy (34.3%).77 It is more common in those with accompanying depression,84 
emotional lability,85 and cognitive impairment.86 Prevalence estimates for disinhibition vary 
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from 6-76%,78, 87 partly due to differences in scales used and research setting (e.g. higher 
prevalence in acute hospital,87 than rehabilitation center68). 
Two studies of 11 and 49 affected patients respectively68, 88 suggested that irritability tends to 
improve over time, and in one (n affected=10) disinhibition improved over time.68 
 
Our searches identified several studies reporting associations with brain lesion location; there 
is no consistent association with disinhibition, irritability, or aggression77, 84, 87, 89-92. 
Irritability/aggression has been associated with higher overall psychopathology, depression and 
anxiety, and poor cognition.91  
 
Our searches identified no clinical trials on the prevention or treatment of personality changes, 
disinhibition or irritability after stroke. In a post-hoc analysis of a double-blind randomized 
controlled trial for treatment of post-stroke depression, antidepressant treatment significantly 
reduced irritability symptoms.91 
 
Psychosis and psychotic symptoms 
‘Psychosis’ refers to disorders involving a severe distortion in thought content. While it is 
commonly used for schizophrenia and related disorders, it also applies to mania and severe 
depression.93 Single psychotic symptoms can also be due to other causes including delirium, 
dementia, or use of psychoactive drugs/dopamine agonists. The most prominent symptoms 
include delusions and hallucinations. Delusions are “erroneous beliefs that usually involve the 
misinterpretation of perceptions and experiences”.93 Hallucinations are abnormal perceptions 
that are not experienced by others, which can occur in any modality and can be simple (e.g. 
light flashes, single sounds) or complex (e.g. seeing whole scenes, hearing voices, seeing 
objects in Lilliputian form (i.e. smaller than normal).56 Most research in stroke populations has 
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used the NPI, which includes two sections on the frequency and severity of any-type of 
delusions and hallucinations63 rather than specific scales e.g. Positive and Negative Symptom 
Scale94 and the Brief Psychotic Rating Scale.95 There is no literature about which is the most 
appropriate scale to use in stroke.  
Our literature search did not identify any high-quality epidemiological studies with active case 
ascertainment.  Two hospital-registry studies identified only 0.4%96 and 3.1%97 of stroke 
patients with a psychotic disorder. The incidence was 1.11 per 1000 person-years, with gradual 
onset at an average of 6.1 months after stroke.97 Single psychotic symptoms not fulfilling 
criteria for syndromal psychotic disorder appear more common. For example, among patients 
admitted to somatic or rehabilitation wards of Dutch nursing homes, delusional symptoms were 
present in 3-10% of patients68, 77 and hallucinations in about 4%.68, 77 Visual hallucinations are 
more common (12%) in patients with occipital strokes.98 Auditory hallucinations were present 
in 4 out of 521 (0.8%) patients with cortical stroke, 99 though they might be more common in 
subcortical strokes.100 Note that we cannot rule out the possibility that some of these patients 
may have had delirium as a cause of psychotic symptoms. There is insufficient information on 
lesion location or the outcome of psychosis and psychotic symptoms.   In a retrospective cohort 
study of 1008 stroke patients, psychosis was the only neuropsychiatric disorder significantly 
associated with a higher mortality rate, but why this should be specific to psychosis is 
obscure.97 No prospective studies on the course and outcome of post-stroke psychosis are 
available.  No clinical trial reported on prevention or treatment of psychosis after stroke.  
 
Research directionsThere is considerable overlap between each  neuropsychiatric 
syndrome.. Depression frequently coexists with anxiety and emotional lability, fatigue is a 
symptom of depression and anxiety, apathy is associated with depression and cognitive 
impairment, and personality changes are associated with emotional lability, depression and 
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cognitive impairment.  This raises the question about whether there are shared underlying 
mechanisms e.g. fluctuations in neurotransmitters, aspects of the inflammatory cascade, 
disrupted functional connectivity in the limbic system and inability to regulate arousal.  Brain 
lesion location seems not to be associated with specific syndromes (except for visual 
hallucinations) 
 . There was a dearth of literature on apathy, even though it is reported to be as common as 
depression. 
There are important knowledge gaps in relation to management. Even for depression there is 
no clear evidence about how to treat patients with mild to moderate post-stroke depression, and 
a dearth of evidence about how to manage people with suspected depression in whom mood 
cannot be formally assessed because of aphasia.  
Further studies exploring the associations and outcome of these syndromes (particularly 
emotional lability, personality change, apathy and psychosis) are needed to identify associated 
factors that might be potential targets for prevention and treatment. Robustly designed 
prevention and treatment trials are needed for each of the syndromes, perhaps by adapting for 
interventions that have been used in other conditions  The trials we identified were generally 
small. Large, high-quality, well-powered trials are needed that will provide definitive answers 
about the effectiveness (or not) of interventions. 
Printed 27 Sep 2013 
Conflict of interest. Prof Mead has received expenses to lecture on post-stroke fatigue at 
international meetings, honoraria to produce a module on exercise after stroke for the World 
Stroke Organisation, and royalties from Later Life Training, for provide teaching material on 
exercise after stroke. A/Prof Hackett has received expenses to lecture on post-stroke 
depression at international meetings. John O'Brien has received travel support and/or 
honoraria for non-promotional lectures from Pfizer, Eisai, Lundbeck, Novartis, Lilly and 
Shire and acted as a consultant for GE Healthcare, Bayer Healthcare, Lilly, TauRx and 
Cytox. Sebastian Köhler reports no conflicts of interest. 
 
 
Role of the authors 
Maree Hackett performed the literature searches for the sections on depression, anxiety and 
emotional lability, and wrote these sections. Professor Mead performed the literature searches 
for fatigue. Sebastian Köhler performed the literature searches for the sections on apathy, 
mania, personality changes and psychosis and wrote the first draft of these sections. John 
O'Brien provided additional references.  All authors commented on drafts of the paper, and all 
contributed equally to the final section on directions for future research. Permissions for the 
figures were obtained by Maree Hackett and Gillian Mead. 
  
Printed 27 Sep 2013 
Table 
Summary of longitudinal studies of post-stroke fatigue, adapted from Journal of 
Psychosomatic Research 
Study Assessment 
points 
Sample size 
reported at 
first time point 
Frequency of 
fatigue at first 
time point 
Frequency of 
fatigue at 
last time 
point 
Schepers 2006 A, 6m, 12m 167 52% 70% 
Van der Port 
2007 
6m, 12 m, 36m 223 68% 58% 
Skaner 2007 3m, 12m 106 69% 58% 
Sisson 1995 1m, 6m 13 92% 85% 
Christensen 
2008 
10d, 3m, 12m, 24 
m 
138 59% 40% 
Snaphaan 2011 2m, 18 m 108 35% 33% 
Hellawell 1999 
(subarachnoid 
haemorrhage 
people) 
6m, 12m, 24m 28 65% 68% 
Ogden 1994 10w, 12m 89 89% 86% 
Noble 2008 24-251d, 335-
672 d 
73 59% 36% 
Van Eijsden 
2012 
D, 24w 242 58% 55% 
Radman 2012 6m, 12m 109 33% 34% 
Abbreviations: A=admission; d=days; D=discharge; m= months; w=weeks 
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Box 1 
Search strategies  
 
Depression search strategy 
 
Medline searched till 19/06/2013 (from date based on last published systematic review) 
 
Stroke AND Depression (2004- )  
  depressive disorder/ or depressive disorder, major/ or depressive disorder, treatment-
resistant/ or dysthymic disorder/ or depression/ or exp antidepressive agents/ 
   (depress$ or dysthymi$ or dysphor$ or antidepress$ or anti-depress$).tw 
 
Anxiety search strategy 
 
Medline (2011- )   anxiety/  exp anxiety disorder/  exp anxiolytic agent/  (anxiety or anxieties or anxious or agoraphobi$ or phobi$ or panic disorder$ or panic 
attack$ or (obsess$ adj3 compuls$) or post?traumatic stress$ or PTSD).tw.  (feel$ adj5 (apprehens$ or dread or disaster$ or fear$ or worry or worried or 
terror)).tw.  anxiety inventory.mp.  anxiety scale.mp. 
 
 
Emotional lability search strategy  
 
Medline (2008- )  crying/ or laughter/  affective symptoms/ or emotions/  (laugh$ or cry$ or weep or weeping or emotional$ or pseudobulbar affect).tw. 
 
 
 
Fatigue  
 
Medline July 2013 all indexed articles, no start date  
 
Fatigue AND stroke (to complement more extensive searches performed for published 
systematic reviews in 2012-See Duncan et al 2012)  
 
Apathy, mania, psychosis, personality changes  
 
Medline search on 15 JULY 2013; all indexed articles, no start date; 
Printed 27 Sep 2013 
Filters: Humans, English language 
 
Stroke AND 
 
(apathy OR apathetic).af   
(mania OR manic OR bipolar OR).af   
(psychosis OR psychotic OR delusions OR hallucinations).af  
AND personality.af  
AND (irritability or irritable).af  
AND (disinhibit* or impulsiv*).af  
 
In September 2013, an additional search was done for euphoria.  
stroke AND (euphoria OR euphoric OR hypomania)).af 
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